Member Info for Jace86

Look like they are due too as they came about this time last year. Q4 sales looked good. Hoping for more the same from Q1 and Q2 although I read they are now reporting on a sales event by sales event basis.

That this company is sat on significant sapphire reserves. As good as cash in the bank as well. Just need Madagascar to sort itself out.

Not seen Welshshark for a while to be honest - I think he and others got wiped out by admin recently. Besides, this looks like a good med term hold like I have bzt on the same strategy. Not every post is for a day trade but I'm sure we can both agree that we are both here to make money? Traders do often come in useful as they bring attention to unloved stocks that are undervalued. Many don't even have an mcap the same as their cash in bank balance.

It'll likely go to 1p just on the run up to good news alone. Then go up from there. Tiny mcap.

Struggled to buy. But now I'm in its better to be in at a slightly higher price than the ask but at least Im in!

Gonna go boom again!

They'll kick themselves as this multibags on the way to results.

Looking encouraging. Good safety profile is a huge plus too!

To be clear I'm a holder. Just not a fan of some bullshit article that is poorly worded and accuses the company of failing a trial deliberately. If you truly are a holder here and not trading it, you'd be concerned of it too. Seems to me the ramp crew is only trading here and not holding one bit.

Very amateurish article. Not well written. Quotes no sources and potentially libellous. Whilst an update from the company would be great, this is not the way to go about getting one for whoever wrote it.

Unless the results generate interest from another company and they foot the bill and take licensing etc

All the way up to December this should keep rising. 1 pound target by then.

Have been on that site for ages. Unless alot more reviews and come in theres no way to prove that it was effective. The data so far shared shows this flopped massively.

Also looking at the loans and from my commercial recovery background, if you was to call up on this loan, what would you be calling on? The firms a shell and you'd force insolvency and have no chance of ever getting anything back. Again, if they are happy to wait because of the numbers they know they are holding on then that too can be taken as a good signal.

Depends on where the firm is located or what their nature of business is that would look to RTO on this. If its someone based in Asia or the Middle East then it shouldn't. Given that the company has been in this semi-dormant state for 7 or so years and the BOD are literally only taking �1 per year tells me that they want the right deal here. In 2016 a Director was appointed with M&A experience and another was in Ford I read. Looking at the loans these would be wiped out by the offset thats on the table with HMRC with plenty to spare. But if all those holding are happy to wait here then I am too after recently putting in. The listing status is key in this firm as well.

Hello - Breast cancer drug on trial looking to penetrate a $5B market. Phase 2/interims due and to be discussed on Wed. Broker target 113p. Very few shares in free float. ADVFN board appears to have alot more posters than here and if you flick through may gain alot more info.

Lost on IMM but thankfully wasnt in FARN. Given that theyve pencilled in a meeting to discuss the results perhaps may bode better this time around? Rather than just dropping the bad news right into the market for a bloodbath.

So far at these levels. Is this the new low point (entry point) for this stock? Price may rise further in anticipation of possible further announcements next week.

Has descended into madness. Anyone short here by any chance? Maybe you should only go short for retraces. I believe it should go back up from here. Money to be made by all no matter your strategy. So long as you get it right and if you don't, remember its you that hasn't, no one else. No need to bicker.

Hopefully beyond 3p as thats where it belongs.